| 000 | 01734 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514234450.0 | ||
| 264 | 0 | _c20060613 | |
| 008 | 200606s 0 0 eng d | ||
| 022 | _a0815-9319 | ||
| 024 | 7 |
_a10.1111/j.1440-1746.2005.03946.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVaughan, Rhys B | |
| 245 | 0 | 0 |
_aVasoconstrictor responses are normal but prostanoid-mediated vasodilatation is enhanced in human cirrhotic mesenteric arteries. _h[electronic resource] |
| 260 |
_bJournal of gastroenterology and hepatology _cAug 2005 |
||
| 300 |
_a1158-64 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aCardiovascular Agents _xpharmacology |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aIndomethacin _xpharmacology |
| 650 | 0 | 4 |
_aLiver Cirrhosis _xphysiopathology |
| 650 | 0 | 4 | _aLiver Transplantation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMesenteric Arteries _xdrug effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNitric Oxide _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNitroarginine _xpharmacology |
| 650 | 0 | 4 |
_aProstaglandins _xbiosynthesis |
| 650 | 0 | 4 |
_aVasoconstriction _xdrug effects |
| 650 | 0 | 4 |
_aVasoconstrictor Agents _xpharmacology |
| 650 | 0 | 4 |
_aVasodilation _xdrug effects |
| 650 | 0 | 4 |
_aVasodilator Agents _xpharmacology |
| 700 | 1 | _aAngus, James A | |
| 700 | 1 | _aAngus, Peter W | |
| 773 | 0 |
_tJournal of gastroenterology and hepatology _gvol. 20 _gno. 8 _gp. 1158-64 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1440-1746.2005.03946.x _zAvailable from publisher's website |
| 999 |
_c15702070 _d15702070 |
||